A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients

Although extensive advancements have been made in treatment against hepatocellular carcinoma (HCC), the prognosis of HCC patients remains unsatisfied. It is now clearly established that extensive epigenetic changes act as a driver in human tumors. This study exploits HCC epigenetic deregulation to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedon, Luca, Dal Bo, Michele, Mossenta, Monica, Busato, Davide, Toffoli, Giuseppe, Polano, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865606/
https://www.ncbi.nlm.nih.gov/pubmed/33499054
http://dx.doi.org/10.3390/ijms22031075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865606/
https://www.ncbi.nlm.nih.gov/pubmed/33499054
http://dx.doi.org/10.3390/ijms22031075

Ejemplares similares